Jck, I would rather see the company sold than issue 30m shares. I think the company would be foolish to refrain from licensing any HOT indications at all until data is available. I would be okay with licensing one or two now to raise cash and then waiting. I do not see raising a measly $30m with 60% dilution as an acceptable option whatsoever.